4.3 Article

Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series

Related references

Note: Only part of the references are listed.
Correction Clinical Neurology

The Italian multiple sclerosis register (vol 40, pg 155, 2019)

Maria Trojano et al.

NEUROLOGICAL SCIENCES (2019)

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Article Clinical Neurology

Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results

Serkan Ozakbas et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2017)

Article Clinical Neurology

Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands

I. Bosca et al.

MULTIPLE SCLEROSIS JOURNAL (2010)

Article Immunology

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis

Luisa M. Villar et al.

JOURNAL OF NEUROIMMUNOLOGY (2009)

Article Clinical Neurology

Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis

P. Perini et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)

Article Clinical Neurology

Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis

LM Villar et al.

ANNALS OF NEUROLOGY (2003)

Article Biochemical Research Methods

A sensitive and reproducible method for the detection of oligoclonal IgM bands

LM Villar et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2001)